Articles

Characterization of gene mutations and copy number changes in acute myeloid leukemia using a rapid target enrichment protocol

Cancer Genome Project, Wellcome Trust Sanger Institute, Cambridge, UK;Department of Haematology, University of Cambridge, UK;Department of Haematology, Addenbrookes Hospital, Cambridge, UK
Department of Haematology, Addenbrookes Hospital, Cambridge, UK;Haematological Cancer Genetics, Wellcome Trust Sanger Institute, Cambridge, UK
Haematological Cancer Genetics, Wellcome Trust Sanger Institute, Cambridge, UK
The Center for the Study of Haematological Malignancies, Nicosia, Cyprus
Sequencing Research and Development, Wellcome Trust Sanger Institute, Cambridge, UK
Cancer Genome Project, Wellcome Trust Sanger Institute, Cambridge, UK
Sequencing Research and Development, Wellcome Trust Sanger Institute, Cambridge, UK
Cancer Genome Project, Wellcome Trust Sanger Institute, Cambridge, UK
Agilent Technologies, Agilent Technologies LDA UK Ltd., Cheadle, UK
Department of Haematology, Addenbrookes Hospital, Cambridge, UK
Department of Haematology, Addenbrookes Hospital, Cambridge, UK
Haematological Cancer Genetics, Wellcome Trust Sanger Institute, Cambridge, UK;EMBL-European Bioinformatics Institute, Cambridge, UK
Haematological Cancer Genetics, Wellcome Trust Sanger Institute, Cambridge, UK
Cancer Genome Project, Wellcome Trust Sanger Institute, Cambridge, UK
Cancer Genome Project, Wellcome Trust Sanger Institute, Cambridge, UK
Instituto de Biomedicina y Biotecnología de Cantabria (CSIC-UC-Sodercan), Departamento de Biología Molecular, Universidad de Cantabria, Santander, Spain
The Center for the Study of Haematological Malignancies, Nicosia, Cyprus;Molecular Haematology and Immunogenetics Center, The Karaiskakio Foundation, Nicosia, Cyprus
Haematological Cancer Genetics, Wellcome Trust Sanger Institute, Cambridge, UK
Vol. 100 No. 2 (2015): February, 2015 https://doi.org/10.3324/haematol.2014.113381